2021 WAO声明：COVID-19疫苗相关过敏反应

2021-02-14 世界过敏组织 World Allergy Organ J . 2021 Feb;14(2):100517.

2021年2月，世界过敏组织(WAO)发布了关于COVID-19疫苗相关过敏反应声明。针对COVID-19（及其变种）的疫苗是目前大流行形式中重要的全球干预措施，疫苗可引起不良反应，但绝大多数免疫后不

中文标题：

英文标题：

COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee

发布机构：

世界过敏组织

发布日期：

2021-02-14

简要介绍：

2021年2月，世界过敏组织(WAO)发布了关于COVID-19疫苗相关过敏反应声明。针对COVID-19（及其变种）的疫苗是目前大流行形式中重要的全球干预措施，疫苗可引起不良反应，但绝大多数免疫后不良反应（AEFI）是疫苗刺激保护性免疫反应的结果。本文主要讨论了当前COVID-19疫苗的反应背景以及作为AEFI减轻过敏反应风险的相关步骤。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=9accd1c002066a4a, title=2021 WAO声明：COVID-19疫苗相关过敏反应, enTitle=COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee, guiderFrom=World Allergy Organ J . 2021 Feb;14(2):100517., authorId=0, author=, summary=2021年2月，世界过敏组织(WAO)发布了关于COVID-19疫苗相关过敏反应声明。针对COVID-19（及其变种）的疫苗是目前大流行形式中重要的全球干预措施，疫苗可引起不良反应，但绝大多数免疫后不, cover=https://img.medsci.cn/202138/1615137389707_2020535.jpg, journalId=0, articlesId=null, associationId=703, associationName=世界过敏组织, associationIntro=世界过敏组织成立于1951年，是一个国际性联合组织，其成员涵盖了全世界89个国家和地区变态反应与临床免疫学会，已经成功举办了21界代表大会。WAO通过不断加强成员国就爱的合作已经向近100个成员国家提供过直接教育援助项目，专题讨论会以及讲师。, copyright=0, guiderPublishedTime=Sun Feb 14 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年2月，世界过敏组织(WAO)发布了关于COVID-19疫苗相关过敏反应声明。针对COVID-19（及其变种）的疫苗是目前大流行形式中重要的全球干预措施，疫苗可引起不良反应，但绝大多数免疫后不良反应（AEFI）是疫苗刺激保护性免疫反应的结果。本文主要讨论了当前COVID-19疫苗的反应背景以及作为AEFI减轻过敏反应风险的相关步骤。</p> </div> </div> </div> <div class="box_info" style="color: #373737;"> </div>, tagList=[TagDto(tagId=103666, tagName=COVID-19疫苗)], categoryList=[CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=35, categoryName=预防与公卫, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=103666, guiderKeyword=COVID-19疫苗, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=13573, appHits=166, showAppHits=0, pcHits=548, showPcHits=13407, likes=1, shares=37, comments=12, approvalStatus=1, publishedTime=Mon Mar 08 01:49:10 CST 2021, publishedTimeString=2021-02-14, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Mon Mar 08 01:16:52 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 19:51:18 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 WAO声明：COVID-19疫苗相关过敏反应.pdf)])

2021 WAO声明：COVID-19疫苗相关过敏反应.pdf

下载请点击：

评论区 (9)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1056517, encodeId=d9c9105651e0a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87855623079, createdName=ms9000001209321368, createdTime=Thu Sep 30 16:21:42 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056515, encodeId=5dfe105651593, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87855623079, createdName=ms9000001209321368, createdTime=Thu Sep 30 16:20:48 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977672, encodeId=db809e767221, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37d85536239, createdName=yejing662277, createdTime=Mon Jun 28 19:32:38 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948782, encodeId=8904948e82f5, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Mar 16 19:11:43 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947287, encodeId=515694e287f4, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210311/c5813bb7a072437182ec5e49b3b4940f/247b38308dd248f4ac4aa8db6cfa9ddf.jpg, createdBy=5d6b5467730, createdName=ms8000001075224150, createdTime=Wed Mar 10 23:29:46 CST 2021, time=2021-03-10, status=1, ipAttribution=)]
2021-09-30 ms9000001209321368

学习

67 0
[GetPortalCommentsPageByObjectIdResponse(id=1056517, encodeId=d9c9105651e0a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87855623079, createdName=ms9000001209321368, createdTime=Thu Sep 30 16:21:42 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056515, encodeId=5dfe105651593, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87855623079, createdName=ms9000001209321368, createdTime=Thu Sep 30 16:20:48 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977672, encodeId=db809e767221, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37d85536239, createdName=yejing662277, createdTime=Mon Jun 28 19:32:38 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948782, encodeId=8904948e82f5, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Mar 16 19:11:43 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947287, encodeId=515694e287f4, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210311/c5813bb7a072437182ec5e49b3b4940f/247b38308dd248f4ac4aa8db6cfa9ddf.jpg, createdBy=5d6b5467730, createdName=ms8000001075224150, createdTime=Wed Mar 10 23:29:46 CST 2021, time=2021-03-10, status=1, ipAttribution=)]
2021-09-30 ms9000001209321368

学习了

53 0
[GetPortalCommentsPageByObjectIdResponse(id=1056517, encodeId=d9c9105651e0a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87855623079, createdName=ms9000001209321368, createdTime=Thu Sep 30 16:21:42 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056515, encodeId=5dfe105651593, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87855623079, createdName=ms9000001209321368, createdTime=Thu Sep 30 16:20:48 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977672, encodeId=db809e767221, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37d85536239, createdName=yejing662277, createdTime=Mon Jun 28 19:32:38 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948782, encodeId=8904948e82f5, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Mar 16 19:11:43 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947287, encodeId=515694e287f4, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210311/c5813bb7a072437182ec5e49b3b4940f/247b38308dd248f4ac4aa8db6cfa9ddf.jpg, createdBy=5d6b5467730, createdName=ms8000001075224150, createdTime=Wed Mar 10 23:29:46 CST 2021, time=2021-03-10, status=1, ipAttribution=)]
2021-06-28 yejing662277

学习了

63 0
[GetPortalCommentsPageByObjectIdResponse(id=1056517, encodeId=d9c9105651e0a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87855623079, createdName=ms9000001209321368, createdTime=Thu Sep 30 16:21:42 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056515, encodeId=5dfe105651593, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87855623079, createdName=ms9000001209321368, createdTime=Thu Sep 30 16:20:48 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977672, encodeId=db809e767221, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37d85536239, createdName=yejing662277, createdTime=Mon Jun 28 19:32:38 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948782, encodeId=8904948e82f5, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Mar 16 19:11:43 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947287, encodeId=515694e287f4, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210311/c5813bb7a072437182ec5e49b3b4940f/247b38308dd248f4ac4aa8db6cfa9ddf.jpg, createdBy=5d6b5467730, createdName=ms8000001075224150, createdTime=Wed Mar 10 23:29:46 CST 2021, time=2021-03-10, status=1, ipAttribution=)]
2021-03-16 jyzxjiangqin

好文章！

107 0
[GetPortalCommentsPageByObjectIdResponse(id=1056517, encodeId=d9c9105651e0a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87855623079, createdName=ms9000001209321368, createdTime=Thu Sep 30 16:21:42 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056515, encodeId=5dfe105651593, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87855623079, createdName=ms9000001209321368, createdTime=Thu Sep 30 16:20:48 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977672, encodeId=db809e767221, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37d85536239, createdName=yejing662277, createdTime=Mon Jun 28 19:32:38 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948782, encodeId=8904948e82f5, content=好文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Mar 16 19:11:43 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947287, encodeId=515694e287f4, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210311/c5813bb7a072437182ec5e49b3b4940f/247b38308dd248f4ac4aa8db6cfa9ddf.jpg, createdBy=5d6b5467730, createdName=ms8000001075224150, createdTime=Wed Mar 10 23:29:46 CST 2021, time=2021-03-10, status=1, ipAttribution=)]
2021-03-10 ms8000001075224150

好

114 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

传染科指南

2021 WAO声明：COVID-19疫苗相关过敏反应

相关指南

拓展阅读

科室

工具

服务